Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06093802

Endoscopic Classification and DISE-Guided Surgery in Pediatric Obstructive Sleep-Disordered Breathing.

Pediatric obstructive sleep apnea (OSA) can lead to severe health issues if untreated. While polysomnography is the gold standard for diagnosis, current surgical treatment in Denmark relies on caregiver reports and clinical exams. Approximately 25% of patients have persistent symptoms post-surgery, indicating the need for better diagnostic and treatment options. Drug-Induced Sleep Endoscopy (DISE) allows dynamic upper airway visualization during mild sedation, aiding in treatment decisions. This research project aims to evaluate the impact of DISE-guided interventions on pediatric OSA outcomes and compare its effectiveness and cost/benefit with traditional diagnostic approaches.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

2 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Regional Hospital Gødstrup

Herning, Region of Central Jutland, 7400, Denmark

Location contact

Anne Louise Bach Christensen, MD

CONTACT

[email protected]

Therese E Ovesen, Prof. DMSc

CONTACT

[email protected]

About this study

Background

1.1 Pediatric Obstructive Sleep Apnea

Pediatric OSA ranges from simple snoring to severe upper airway obstruction during sleep. Left untreated, it can lead to significant health issues, especially in children, impacting their cognitive development, learning, and social interactions.

1.2 Diagnostics and Surgical Strategies

Polysomnography (PSG) is the gold standard for diagnosing OSA. In Denmark, PSG isn't widely used due to equipment and setup constraints.

Surgical treatment for pediatric OSA in Denmark relies primarily on clinical examination of the tonsils and parental reports of symptoms.

1.3 Drug-Induced Sleep Endoscopy (DISE)

DISE is a method for visualizing upper airway collapse during sleep using a flexible endoscope. It is increasingly used to guide surgical decisions for pediatric OSA in various countries, though its clinical impact remains uncertain.

  • Aims

This research project aims to evaluate the impact of DISE-guided surgical interventions on pediatric OSA outcomes and compare the effectiveness of a DISE-inclusive diagnostic approach with the traditional pediatric OSA workup. The specific objectives are:

Evaluate treatment outcomes, including the reduction in persistent OSA post-surgery.

Classify and compare patterns of airway obstruction observed during DISE in surgically naive children.

Compare diagnostic approaches in terms of cost, time, and benefits. Identify adverse events and complications related to sedation and surgery. Assess the feasibility of DISE in Danish patients through a pilot study.

  • Methods

3.1 Randomized Controlled Trial (RCT)

Patients undergo initial clinical examination and home respiratory polygraphy (HRP). Based on AAO-HNSF criteria, patients with OSA will undergo DISE. The sample size for the RCT is 250 patients, with 125 in each group.

3.2 Statistics

Statistical analysis will involve Chi-square tests, logistic regression, and T-tests for comparisons between groups.

3.3 Sedation Protocol

Sedation will use propofol to induce a state similar to natural sleep, guided by preoperative polysomnography.

3.4 Assessment of Obstruction

Obstruction characteristics will be documented using the International Pediatric Sleep Endoscopy Scale (IPSES).

3.5 Follow-up

Patients will have two follow-up appointments at three and 12 months postoperatively, including clinical examination, HRP, and re-DISE at three months for both groups.

  • Outcomes

4.1 Primary Outcome

The primary outcome is the treatment failure rate, comparing the proportion of patients with persistent OSA post-surgery in the DISE-guided surgery group to the non-DISE-guided surgery group.

4.2 Secondary Outcomes

Secondary outcomes include evaluation of DISE findings, changes in apnea-hypopnea index (AHI), quality of life improvement, DISE-score/airway obstruction pattern, and identification of adverse events and complications.

4.3 Confounding Factors

Population characteristics, such as age, obesity (BMI), and gender, will be considered.

  • Ethical Considerations

In cases where no obstruction is identified related to tonsils or adenoids, alternative treatment options will be discussed with parents. Privacy and informed consent are required. The study will follow ethical and data protection regulations

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Surgically naïve, otherwise healthy, non-syndromic children aged 2-12 years with suspected oSDB of any severity
  • One completed Pediatric Sleep Questionnaire - Sleep Related Breathing Disorder (PSQ)
  • Home Respiratory Polygraphy (HRP) and/or in-house Polysomnography (PSG) showing OSA according to the definition of AAO-HNSF

Exclusion criteria

  • Syndromes and congenital/acquired craniofacial abnormalities/malformations of the upper airways
  • Neurological conditions affecting upper airway muscle tone
  • Lower airway disease (tracheomalacia, asthma)
  • Previous surgery of the nose/pharynx/larynx

Treatment and study plan

Drug-induced Sleep Endoscopy findings (identified obstruction sites)

Diagnostic Test

As described above

Other names: Turbinoplasty, Nasal steroids

Primary outcomes

  1. Treatment Failure Rate

    Time frame: one year post surgery

    Proportion of patients, who exhibit persistent OSA post-surgery in the DISE-guided surgery group compared to the non-DISE-guided surgery group (controls).

Secondary outcomes

  1. DISE findings

    Time frame: initial assessment and one year post surgery

    Evaluation of DISE findings and pediatric VOTE:

    Assessing obstruction degree and sites in both groups.

    Quality of Life Improvement:

    DISE-score and Airway Obstruction Pattern:

    Identifying and comparing anatomical obstruction sites and severity during DISE in both groups.

  2. OSA (AHI)

    Time frame: initial assessment and one year post surgery

    Change in apnea-hypopnea index (AHI):

    Analyzing AHI and oxygen saturation differences between baseline and post-treatment in both groups.

  3. Quality of Life (OSA-18)

    Time frame: initial assessment and one year post surgery

    Evaluation of symptom changes and quality of life using the OSA-18 questionnaire in both groups.

  4. Sedation-related and surgical complications

    Time frame: initial assessment and one year post surgery

    Adverse Events and Complications:

    Investigation of the incidence and severity of sedation-related events and surgical complications in both groups, including postoperative hemorrhage, infection, recurrent symptoms post-tonsillotomy, and symptom improvement without treatment.

Study contacts

Contact information is provided by the study sponsor or research team.

Jannik Bertelsen, MD PhD

CONTACT

[email protected]

Mascha Hildebrandt, MD

CONTACT

[email protected]

+4541289051

Sponsors and collaborators

Lead sponsor

Regional Hospital West Jutland

Other

Collaborators

  • University Hospital, Antwerp

Registry information

Official study title

Endoscopic Classification of Airway Obstruction and Drug Induced Sleep Endoscopy-Guided Surgery in Children With Obstructive Sleep-Disordered Breathing.

Acronym: DISE

Important dates

Study start
2025
Primary completion
2026
Study completion
2029
First posted
Oct 23, 2023
Registry last updated
Oct 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.